Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07635823Not ApplicableRecruiting

Adaptive DBS for PD

Role: collaborator

NCT07577050Phase 2Not Yet Recruiting

A Phase II Study of NB001 for Acute Migraine Treatment

Role: collaborator

NCT06871839Recruiting

The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease

Role: collaborator

NCT05014893Not ApplicableRecruiting

Neural Mechanisms of Cognitive Assessment and Rehabilitation for Cognitive Decline

Role: collaborator

All 4 trials loaded